Tags

Type your tag names separated by a space and hit enter

[Uroporphyrinogen decarboxylase in erythrocytes: studies on the primary genetic enzyme defect in chronic hepatic porphyria (author's transl)].
J Clin Chem Clin Biochem 1978; 16(9):513-7JC

Abstract

In chronic hepatic porphyria, including the clinical phase, porphyria cutanea tarda, the activity of uroporphyrinogen decarboxylase is decreased not only in the liver, but also in the erythrocytes. The synonomous decrease in the enzymic activity in liver and erythrocytes in both familial and sporadic hepatic porphyria shows that the disturbance of this enzyme is the primary genetic defect of this condition; inheritance of the defect is probably autosomal and dominant. The clinical manifestation of disturbances of porphyrin metabolism are precipitated, however, by additional factors, such as liver damage, alcohol, oestrogens and neoplastic growths. In the absence of these other pathogenic influences, the enzyme defect is compensated and does not result in disturbances of haem or haemoglobin synthesis, either in the liver or the bone marrow.

Authors

No affiliation info availableNo affiliation info available

Pub Type(s)

English Abstract
Journal Article

Language

ger

PubMed ID

712342

Citation

von Tiepermann, R, and M Doss. "[Uroporphyrinogen Decarboxylase in Erythrocytes: Studies On the Primary Genetic Enzyme Defect in Chronic Hepatic Porphyria (author's Transl)]." Journal of Clinical Chemistry and Clinical Biochemistry. Zeitschrift Fur Klinische Chemie Und Klinische Biochemie, vol. 16, no. 9, 1978, pp. 513-7.
von Tiepermann R, Doss M. [Uroporphyrinogen decarboxylase in erythrocytes: studies on the primary genetic enzyme defect in chronic hepatic porphyria (author's transl)]. J Clin Chem Clin Biochem. 1978;16(9):513-7.
von Tiepermann, R., & Doss, M. (1978). [Uroporphyrinogen decarboxylase in erythrocytes: studies on the primary genetic enzyme defect in chronic hepatic porphyria (author's transl)]. Journal of Clinical Chemistry and Clinical Biochemistry. Zeitschrift Fur Klinische Chemie Und Klinische Biochemie, 16(9), pp. 513-7.
von Tiepermann R, Doss M. [Uroporphyrinogen Decarboxylase in Erythrocytes: Studies On the Primary Genetic Enzyme Defect in Chronic Hepatic Porphyria (author's Transl)]. J Clin Chem Clin Biochem. 1978;16(9):513-7. PubMed PMID: 712342.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Uroporphyrinogen decarboxylase in erythrocytes: studies on the primary genetic enzyme defect in chronic hepatic porphyria (author's transl)]. AU - von Tiepermann,R, AU - Doss,M, PY - 1978/9/1/pubmed PY - 1978/9/1/medline PY - 1978/9/1/entrez SP - 513 EP - 7 JF - Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie JO - J. Clin. Chem. Clin. Biochem. VL - 16 IS - 9 N2 - In chronic hepatic porphyria, including the clinical phase, porphyria cutanea tarda, the activity of uroporphyrinogen decarboxylase is decreased not only in the liver, but also in the erythrocytes. The synonomous decrease in the enzymic activity in liver and erythrocytes in both familial and sporadic hepatic porphyria shows that the disturbance of this enzyme is the primary genetic defect of this condition; inheritance of the defect is probably autosomal and dominant. The clinical manifestation of disturbances of porphyrin metabolism are precipitated, however, by additional factors, such as liver damage, alcohol, oestrogens and neoplastic growths. In the absence of these other pathogenic influences, the enzyme defect is compensated and does not result in disturbances of haem or haemoglobin synthesis, either in the liver or the bone marrow. SN - 0340-076X UR - https://www.unboundmedicine.com/medline/citation/712342/[Uroporphyrinogen_decarboxylase_in_erythrocytes:_studies_on_the_primary_genetic_enzyme_defect_in_chronic_hepatic_porphyria__author's_transl_]_ L2 - http://www.diseaseinfosearch.org/result/5879 DB - PRIME DP - Unbound Medicine ER -